Saudi cancer center expands radiopharmaceutical care nationwide

By AI, Created 9:43 AM UTC, May 20, 2026, /AGP/ – King Faisal Specialist Hospital and Research Centre says its cyclotron and radiopharmaceutical network now supplies more than 30,000 doses a year to 45 centers in 20 Saudi cities. The model aims to speed access to time-sensitive cancer imaging and treatment while reducing reliance on imports.

Why it matters: - Radiopharmaceuticals are time-sensitive and can lose value when transport takes too long. - A distributed supply model can help patients outside major cities get advanced imaging and targeted cancer treatment closer to home. - The approach shows how specialized cancer care can move beyond a single hospital and into a national network.

What happened: - King Faisal Specialist Hospital and Research Centre in Riyadh says its in-house cyclotron and radiopharmaceutical program now supports a nationwide cancer care network. - The hospital produces more than 35 types of radiopharmaceuticals. - The program supplies over 30,000 doses annually. - Those doses reach 45 specialized centers across 20 cities in Saudi Arabia. - The hospital says the model is designed to improve access to time-sensitive diagnostic and therapeutic nuclear medicine services.

The details: - Local production reduces reliance on imports. - The distribution system is meant to keep radiopharmaceuticals usable by limiting delays that can degrade them. - Patients can receive critical imaging and targeted treatments closer to where they live. - The hospital says the model extends specialized cancer care beyond the walls of the main institution. - King Faisal Specialist Hospital & Research Centre has been ranked first in the Middle East and North Africa and 12th globally among the world’s top 250 Academic Medical Centers for 2026. - Brand Finance 2025 named the hospital the most valuable healthcare brand in the Kingdom and the Middle East. - Newsweek listed the hospital among the World’s Best Hospitals 2026, World’s Best Smart Hospitals 2026 and World’s Best Specialized Hospitals 2026.

Between the lines: - The model reflects a broader shift from centralized academic medical hubs toward networked systems that can spread expertise across wider geographies. - That shift is especially relevant in markets where access to advanced cancer care varies by region. - The hospital’s setup offers a working example of how system design, not only physical expansion, can widen access. - Whether the model can move into other countries will depend on regulatory, logistical and reimbursement differences. - The hospital’s role as a Silver Sponsor at the Milken Institute Global Conference 2026 also places the model in a broader conversation about scaling healthcare innovation.

What’s next: - The hospital’s distribution model may inform future discussions on how to deliver advanced cancer care across larger and more fragmented health systems. - Adaptation in other markets will likely hinge on local rules for production, transport and payment. - Leaders at the Milken Institute Global Conference 2026 in Los Angeles are expected to discuss how innovation can translate into system-level impact.